Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
4
×
boston blog main
boston top stories
gene editing
life sciences
national blog main
biotech
crispr
editas medicine
san francisco blog main
allergan
clinical trials
cynthia collins
deals
feng zhang
national top stories
san francisco top stories
abbvie
agios therapeutics
alzheimer's disease
base editing
branden moriarty
broad institute
cas13
crispr therapeutics
crispr-cas9
david liu
david walt
diagnostics
dna
drugs
editor
editr
enzyme
harvard university
illumina
intellia therapeutics
jennifer doudna
jim collins
john evans
What
editing
4
×
gene
crispr
editas
experimental
medicine
medicines
abbvie
allergan
alliance
beam
bio
biotech
blessing
bosley
cas
ceo
check
clinical
create
cusp
depart
diagnostic
diseases
editor
exits
fix
founders
genetic
gotten
harvard
heats
high
human
humans
jump
katrine
launches
mass
million
Language
unset
Current search:
editing
×
boston
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
5 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M